Analysis of the symptom response to esomeprazole 20 mg over days 1–4 of a 14-day course of treatment for frequent heartburn: results of two randomised controlled trials
Sign Up to like & getrecommendations! Published in 2019 at "BMJ Open Gastroenterology"
DOI: 10.1136/bmjgast-2019-000278
Abstract: Background Drug exposure and corresponding antisecretory effects increase over the first 4–5 days of esomeprazole treatment. To date, this effect has not been correlated with symptomatic improvement. Therefore, the efficacy of esomeprazole was evaluated on… read more here.
Keywords: heartburn; treatment; free days; heartburn free ... See more keywords
Effects of Tegoprazan Versus Esomeprazole on Nighttime Heartburn and Sleep Quality in Gastroesophageal Reflux Disease: A Multicenter Double-blind Randomized Controlled Trial
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Neurogastroenterology and Motility"
DOI: 10.5056/jnm22104
Abstract: Background/Aims Patients with gastroesophageal reflux disease (GERD) frequently experience nighttime heartburn and sleep disturbance. Tegoprazan is a new potassium-competitive acid blocker that can rapidly block acid secretion. This study aims to evaluate the efficacy of… read more here.
Keywords: heartburn sleep; nighttime heartburn; reflux disease; heartburn free ... See more keywords